Create an Account
  1. Home
  2. Meetings
  3. General Ophthalmology

Patient Care Update: Neurotrophic Keratitis Diagnosis, Treatment, and Referrals

Patient Care Update Neurotrophic Keratitis Diagnosis Treatment and Referrals
Media formats available:
Details
Presenters

  • Overview

    Neurotrophic keratitis can lead to epithelial breakdown, impairment of healing, and ultimately to the development of corneal ulceration, melting and perforation.

    Join the faculty for an engaging presentation on the potential causes of neurotrophic keratitis, how to differentiate it from similar diseases, and when referrals may be necessary. Treatment options will also be discussed, including the mechanisms of action of newer therapies and when they should be introduced.

    This live, virtual symposium will also include case discussions followed by an audience question-and-answer session.

    Supported by an unrestricted educational grant from Dompé. 

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Describe the stages of neurotrophic keratitis, and how to differentiate it from similar diseases
    • Recognize the various potential causes of neurotrophic keratitis and when referrals may be necessary
    • Summarize mechanisms of action of newer treatments and when they should be introduced into treatment regimens for neurotrophic keratitis
    • Identify the relationships between disease characteristics, drug, treatment frequency, visual and anatomic outcomes

    • Accreditation

      Credit Designation Statement

      Evolve Medical Education LLC (Evolve) is an approved COPE administrator.

      This activity, COPE Activity Number 122519, is accredited by COPE for continuing education for optometrists. 
      This course is approved for 1 hour of CE. 

      Course #74365-AS
      Activity #122519

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Kelly K. Nichols, OD, MPH, PhD, FAAO

      Kelly K. Nichols, OD, MPH, PhD, FAAO

      Dean of the School of Optometry
      University of Alabama at Birmingham
      Birmingham, AL


      Francis S. Mah, MD

      Francis S. Mah, MD

      Director of Corneal and External Disease
      Co-Director of Refractive Surgery
      Scripps Clinic

      La Jolla, CA
       


      Douglas K. Devries, OD

      Douglas K. Devries, OD

      Co-Founder
      Eye Care Associates of Nevada
      Sparks, NV


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

      The following faculty/staff members have the following financial relationships with commercial interests:

      Kelly K. Nichols, OD, MPH, PhD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Bruder, Dompé, HanAll Bio, Kala Pharmaceuticals, Novartis, Osmotica, Oyster Point Pharma, Sight Sciences, Thea, Tarsis, and Topivent. Grant/Research Support: Allergan, Kala Pharmaceuticals, NIH, and Tear Science. Stock/Shareholder: Alcon Vision, Acquiom, LacriScience, and Tear Film Innovations.

      Francis S. Mah, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, Eyenovia, Glaukos, iView, Johnson & Johnson Vision, Nevakar, Novartis, Ocular Science, and RxSight. 

      Douglas K. Devries, OD, has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Advisory Board: Akorn, Alcon, Allergan, Avelino, Azura, Bausch + Lomb, BlephEx, Bio Tissue, Bruder, Eyevance, Johnson & Johnson Vision, Kala Pharmaceuticals, Novartis, OcuSoft, Quidel, Sight Sciences, Science Based Health, Sun Pharmaceutical Industries, Tarsus, Tearlab, Thea, and Visus. Speaker’s Bureau: Allergan, Bausch + Lomb, Bio Tissue, BlephEx, Bruder, Eyevance, Kala Pharmaceuticals, Lumenis, Johnson & Johnson Vision, OcuSoft, Sight Sciences, Science Based Health, Sun Pharmaceutical Industries, and Tearlab. Stock/Shareholder: RPS.

      The Evolve staff and planners have no financial relationships with commercial interests.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Dompé.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio

    Loading...

    00:00
    00:00
      Register

      We're glad to see you're enjoying Evolve Medical Education…
      but how about a more personalized experience?

      Register for free